Promising findings by researchers at Baylor College of Medicine and collaborating institutions could lead to the development ...

The company continues to build validation data and believes its lower cost proposition can help it gain leverage in the European market where molecular tests are not reimbursed.

It’s good news in the fight against colorectal cancer: A new test can detect the disease with a simple blood draw. But don’t ...

University of Pittsburgh scientists have independently validated a new blood test platform that can simultaneously measure ...

A team of cardiologists shared tips and tricks for clinicians to address the pitfalls they may encounter when conducting ...

POC HBV testing was associated with faster turnaround time for results and higher rates of treatment initiation when compared with standard laboratory-based assays.

NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia ...

In a recent article published in the journal Nature Communications, researchers have developed a novel plasmonic biosensor as ...

Exact Sciences expects to launch the updated test, which has higher specificity than its predecessor, with Medicare coverage and guideline inclusion in 2025.

Circulating tumor DNA is a promising tool for the detection and surveillance of HPV-positive oropharyngeal squamous cell ...

In a significant advancement for point-of-care medical diagnostics, a team of researchers from UCLA has introduced a deep ...

Cologuard Plus test, the company’s next-generation multi-target stool DNA test. The Cologuard Plus test is now approved for ...